EP0449699A3
Pyrazole derivatives as angiotensin ii-receptor antagonists, process for their preparation and pharmaceutical compositions containing them
Abstract
The present invention relates to the derivatives of formula (I): As well as their addition salts and their therapeutic use, in particular for the treatment of cardiovascular diseases, in particular for the treatment of hypertension and heart failure.
Term
Term ended
Projected expiry passed 18 March 2011, 15.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0007019A1 | Cites | European Patent Office (EPO) | A | Search report |
| EP0086647A2 | Cites | European Patent Office (EPO) | A | Search report |
| EP0323841A2 | Cites | European Patent Office (EPO) | AD | Search report |
| EP0446062A1 | Cites | European Patent Office (EPO) | E | Search report |
| DE2319281A1 | Cites | Germany | A | Search report |
| DE2347015A1 | Cites | Germany | A | Search report |
| LIEBIGS ANNALEN DER CHEMIE vol. 1980, no. 9, 1980, pages 1392 - 1401 B. K]BEL | Non-patent | – | – | Search report |
13 members in 11 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 9003485 | France | A | |
| 9003485 | France | A | |
| 9003485 | France | – | |
| FR19900003485 | – | – | – |
Members13
| Document | Office | Kind | |
|---|---|---|---|
| AU7359191A | Australia | A | |
| CA2038428A1 | Canada | A1 | |
| FR2659655A1 | France | A1 | |
| IE910766A1 | Ireland | A1 | |
| EP0449699A2 | European Patent Office (EPO) | A2 | |
| PT97056A | Portugal | A | |
| KR910016708A | Republic of Korea | A | |
| ZA911925B | South Africa | B | |
| IL97576A0 | Israel | A0 | |
| FR2659655B1 | France | B1 | |
| JPH04234851A | Japan | A | |
| EP0449699A3This record | European Patent Office (EPO) | A3 | |
| NZ237445A | New Zealand | A |
7 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 0449699
- Publication, DOCDB
- 0449699
- Publication, EPODOC
- EP0449699
- Application
- 400717
- Application, DOCDB
- 91400717
- Application, EPODOC
- EP19910400717
Titles3
- German
- Pyrazol-Derivate als Angiotensin-II-Receptor-Antagonisten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
- English
- Pyrazole derivatives as angiotensin II-receptor antagonists, process for their preparation and pharmaceutical compositions containing them
- French
- Dérivés de pyrazole antagonistes des récepteurs à l'angiotensine II, leurs procédés de préparation, compositions pharmaceutiques les contenant
Classification
- CPC, 7
- C07D403/10
- C07D231/12
- C07D231/20
- C07D231/22
- C07D405/14
- C07D409/10
- A61P9/12
- IPC, 10
- A61P9 12
- C07D231 10
- C07D231 12
- C07D231 20
- C07D231 22
- C07D403 10
- C07D405 14
- C07D409 10
- C07D409 14
- A61K31 415
Designated states1
- Contracting states, 1
- Sweden